David D. Ho
21Patents
7h-index
24Co-inventors
69Inventor score
Filing activity: Jun 7, 1991 → Aug 19, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7923013B2 | Glycolipids and analogues thereof as antigens for NKT cells | Chemistry; Metallurgy | 34 | Active |
| US6235504A | Methods for identifying genomic equivalent markers and their use in quantitating cells and polynucleotide sequences therein | Chemistry; Metallurgy | 25 | Expired |
| US5178865A | Chinese herbal extracts in the treatment of HIV related disease in vitro | Human Necessities | 22 | Expired |
| US6298343A | Methods for intelligent universal database search engines | Emerging Cross-Sectional Technologies | 16 | Expired |
| US8163290B2 | Glycolipids and analogues thereof as antigens for NKT cells | Chemistry; Metallurgy | 13 | Active |
| US6714906B1 | Rapid phase identification method | Physics | 9 | Expired |
| US8637024B2 | Fusion antibodies for HIV therapy | Chemistry; Metallurgy | 8 | Active |
| US7981428B2 | Flu vaccines and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US7534434B2 | Glycolipids and analogues thereof as antigens for NK T cells | Chemistry; Metallurgy | 3 | Active |
| US6190871A | Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) gp120 and methods of use | Chemistry; Metallurgy | 1 | Expired |
| US10308707B2 | Bispecific HIV-1-neutralizing antibodies | Chemistry; Metallurgy | 1 | Active |
| US9790276B2 | Glycan-modified anti-CD4 antibodies for HIV prevention and therapy | Chemistry; Metallurgy | 1 | Active |
| US9884905B2 | Bispecific HIV-1 neutralizing antibodies | Chemistry; Metallurgy | 1 | Active |
| US9587012B2 | Bispecific HIV-1 neutralizing antibodies | Chemistry; Metallurgy | 1 | Active |
| US12098187B2 | Bispecific HIV-1-neutralizing antibodies | Chemistry; Metallurgy | 0 | Active |
| US6054284A | Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use | Chemistry; Metallurgy | 0 | Expired |
| US8586051B2 | Glycolipids and analogues thereof as antigens for NKT cells | Chemistry; Metallurgy | 0 | Active |
| US9587022B2 | Glycan-modified anti-CD4 antibody with improved HIV-1 neutralizing activity | Chemistry; Metallurgy | 0 | Active |
| US12012451B2 | Engineering pH-dependent antigen binding activity into anti-HIV antibodies with improved pharmacokinetics | Chemistry; Metallurgy | 0 | Active |
| US10654943B2 | Tri-specific antibodies for HIV therapy | Chemistry; Metallurgy | 0 | Active |
| US8030029B2 | Flu vaccines and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.